Table 1.
Baseline characteristics of study participants
| DICA-NUTS group | DICA group | |
|---|---|---|
| Male sex—no./total no. (%) | 143/193 (74.1) | 137/195 (70.3) |
| Age, in years, mean (SD) | 60.3 (9.7) (n = 193) | 58.4 (9.1) (n = 195) |
| Race—no./total no. (%) | ||
| White | 134/193 (69.4) | 120/195 (61.5) |
| Black | 21/193 (10.9) | 23/195 (11.8) |
| Multiracial | 35/193 (18.1) | 45/195 (23.1) |
| Other race | 3/193 (1.6) | 7/195 (3.6) |
| Family status—no./total no. (%) | ||
| Married | 114/193 (59.1) | 109/195 (55.9) |
| Other | 79/193 (40.9) | 86/195 (44.1) |
| Scholarity (in years of study)—no./total no. (%) | ||
| < 5 years | 34/191 (17.8) | 38/193 (19.7) |
| 5 to < 8 years | 34/191 (17.8) | 41/193 (21.2) |
| 8 to < 11 years | 25/191 (13.1) | 30/193 (15.5) |
| 11 to < 15 years | 58/191 (30.4) | 52/193 (26.9) |
| ≥ 15 years | 40/191 (20.9) | 32/193 (16.6) |
| Number of minimum wages—no./total no. (%)a | ||
| > 2 | 91/191 (47.7) | 68/193 (35.2) |
| ≤ 2 | 100/191 (52.4) | 125/193 (64.8) |
| Current smokers—no./total no. (%) | 14/191 (7.3) | 23/193 (11.9) |
| Alcohol consumption, in g/day, median (IQR) | 0 (0—1) | 0 (0—0) |
| Physical activity—no./total no. (%) | ||
| Sedentarism/low levels | 68/191 (35.6) | 59/193 (30.6) |
| Moderate/high levels | 123/191 (64.4) | 134/193 (69.4) |
| Time of diagnosis of MI, in days, mean (SD) | 104.2 (34.9) (n = 193) | 108.7 (36.1) (n = 195) |
| ST-Elevation MI—no./total no. (%)b | 105/187 (56.2) | 116/187 (62) |
| non-ST-Elevation MI—no./total no. (%)b | 82/187 (43.9) | 71/187 (38) |
| Treatment post-event—no./total no. (%) | ||
| Clinical treatment | 17/193 (8.8) | 25/195 (12.8) |
| Angioplasty | 19/193 (9.8) | 18/195 (9.2) |
| Angioplasty with stent | 151/193 (78.2) | 148/195 (75.9) |
| Surgery (bypass) | 6/193 (3.1%) | 4/195 (2.1%) |
| Statin treatment regimen—no./total no. (%) | ||
| No statin/low intensity | 9/191 (4.7%) | 16/193 (8.3%) |
| Moderate intensity | 109/191 (57.1%) | 101/193 (52.3%) |
| High intensity | 73/191 (38.2%) | 76/193 (39.4%) |
| Other drugs in use—no./total no. (%) | ||
| Antihypertensive | 184/191 (96.3%) | 187/193 (96.9%) |
| Antiplatelet | 185/191 (96.9%) | 186/193 (96.4%) |
| Glucose-lowering drugs | 57/191 (29.8%) | 40/193 (20.7%) |
| Insulin | 20/191 (10.5%) | 17/193 (8.8%) |
| Previous medical diagnosis—no./total no. (%)c | ||
| Dyslipidaemia | 72/191 (37.7) | 84/194 (43.3) |
| Hypertension | 123/191 (64.4) | 116/194 (59.8) |
| Type 2 diabetes mellitus | 62/191 (32.5) | 49/194 (25.7) |
| Stroke | 10/191 (5.2) | 12/194 (6.2) |
| Glomerular filtration rate, in mL/min/1.73m2, median (IQR) | 75.3 (64—88.7) (n = 188) | 77.8 (66.1—92.9) (n = 190) |
MI Myocardial infarction, SD Standard deviation, IQR Interquartile range
aOne Brazilian minimum wage represents US$ 285.00. Classification was based on self-reported household income
bObtained from medical records
cSelf-reported